We are dedicated to acquiring and providing strategic resources and expansion capital to innovative healthcare companies that strive to provide much needed healthcare and related products to patients in need. By partnering with exceptional entrepreneurs we aim to help to create market-leading products in the biomedical and healthcare sector. As entrepreneurs and investors with operational and technical expertise we embrace a collaborative approach to capital formation and business development.
ABOUT QBIO by OUR CEO
QUARTERLY & ANNUAL REPORTS
PRESS AND NEWS
Company and Yorkville Advisors have agreed to extend the maturity of the remaining debt balance for 12 months NEW YORK, October 12, 2017 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration Company, announced today that their funding partner...
Sphaera to Provide Proprietary Patentable Analogue of QBM-001 for IND filing NEW YORK, September 19, 2017 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, announced today a partnership with Sphaera Pharma to develop a new...
Funding Provides Capital to Meet Near Term Milestones and CatalystsNEW YORK, August 2, 2017 /PRNewswire/ --Q BioMed Inc. (OTCQB: QBIO) is pleased to announce the closing of a $3,050,390 equity financing. The financing with a small group of accredited investors...
Copyright © 2017 Q BioMed, Inc. All Rights Reserved
501 Madison Ave, 14th Floor
New York, NY 10022 USA
P: +1 888 357 2435